Corrigendum: 7-Ethyl-10-Hydroxycamptothecin, A DNA Topoisomerase I Inhibitor, Performs BRD4 Inhibitory Activity and Inhibits Human Leukemic Cell Growth
Saved in:
Main Authors: | Airong Wang (Author), Lingling Li (Author), Mengya Li (Author), Shujuan Wang (Author), Chong Wang (Author) |
---|---|
Format: | Book |
Published: |
Frontiers Media S.A.,
2021-08-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
7-Ethyl-10-Hydroxycamptothecin, a DNA Topoisomerase I Inhibitor, Performs BRD4 Inhibitory Activity and Inhibits Human Leukemic Cell Growth
by: Airong Wang, et al.
Published: (2021) -
Improved lymphatic targeting: effect and mechanism of synthetic borneol on lymph node uptake of 7-ethyl-10-hydroxycamptothecin nanoliposomes following subcutaneous administration
by: Tiantian Ye, et al.
Published: (2018) -
Discovery of highly potent and selective 7-ethyl-10-hydroxycamptothecin-glucose conjugates as potential anti-colorectal cancer agents
by: Chao Yang, et al.
Published: (2022) -
Development of a method to quantify total and free irinotecan and 7-ethyl-10-hydroxycamptothecin (SN-38) for pharmacokinetic and bio-distribution studies after administration of irinotecan liposomal formulation
by: Wenqian Yang, et al.
Published: (2019) -
Effect of verapamil on the pharmacokinetics of hydroxycamptothecin and its potential mechanism
by: Hua Xing, et al.
Published: (2020)